MyD88 is a mediator for the activation of Nrf2

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 46-51

  Kim, Kyun Ha ^a   Lyu, Ji Hyo ^a   Koo, Sung Tae ^a   Oh, Sei Ryang ^b   Lee, Hyeong Kyu ^b   Ahn, Kyung Seop ^b   Sadikot, Ruxana T ^c   Joo, Myungsoo ^a,d  

^a Pusan National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gene regulation; Inflammation; Macrophages; Nrf2; SiRNA; TLR4 signaling

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; HEME OXYGENASE 1; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CATALYSIS; CELLULAR DISTRIBUTION; EPIGENETICS; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GLUTAMATE-CYSTEINE LIGASE; HEME OXYGENASE-1; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 78650860386     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.051     Document Type: Article

References (35)

1. Nathan C., Ding A. Non resolving inflammation. Cell 2010, 140:871-882.
2. Beutler B., Rietschel E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 2003, 3:169-176.
3. Kooguchi K., Hashimoto S., Kobayashi A., Kitamura Y., Kudoh I., Wiener-Kronish J., et al. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia1. Infect. Immun. 1998, 66:3164-3169.
4. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive. Immun. Nat. 1997, 388:394-397.
5. Muzio M., Natoli G., Saccani S., Levrero M., Mantovani A. The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 1998, 187:2097-2101.
6. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 1998, 95:588-593.
7. Zhang F.X., Kirschning C.J., Mancinelli R., Xu X.P., Jin Y., Faure E., et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 1999, 274:7611-7614.
8. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001, 13:85-94.
9. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z. MyD88 an adapter that recruits IRAK to the IL-1 receptor complex2. Immunity 1997, 7:837-847.
10. Sharma S., Tenoever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway1. Science 2003, 300:1148-1151.
11. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway3. Nat. Immunol. 2003, 4:491-496.
12. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling2. J. Immunol. 2002, 169:6668-6672.
13. Bjorkbacka H., Fitzgerald K.A., Huet F., Li X., Gregory J.A., Lee M.A., et al. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades1. Physiol. Genomics 2004, 19:319-330.
14. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
15. Lee J.M., Li J., Johnson D.A., Stein T.D., Kraft A.D., Calkins M.J., et al. Nrf2, a multi-organ protector?. FASEB J. 2005, 19:1061-1066.
16. Nguyen T., Nioi P., Pickett C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009, 284:13291-13295.
17. Chan K., Kan Y.W. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. USA 1999, 96:12731-12736.
18. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 2004, 114:1248-1259.
19. Rangasamy T., Guo J., Mitzner W.A., Roman J., Singh A., Fryer A.D., et al. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 2005, 202:47-59.
20. Joo M., Kwon M., Sadikot R.T., Kingsley P.J., Marnett L.J., Blackwell T.S., et al. Induction and function of lipocalin prostaglandin D synthase in host immunity. J. Immunol. 2007, 179:2565-2575.
21. Ishii T., Itoh K., Sato H., Bannai S. Oxidative stress-inducible proteins in macrophages. Free Radical Res. 1999, 31:351-355.
22. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 2000, 275:16023-16029.
23. Legrand-Poels S., Maniglia S., Boelaert J.R., Piette J. Activation of the transcription factor NF-kappaB in lipopolysaccharide-stimulated U937 cells. Biochem. Pharmacol. 1997, 53:339-346.
24. Segal B.H., Han W., Bushey J.J., Joo M., Bhatti Z., Feminella J., et al. NADPH oxidase limits innate immune responses in the lungs in mice1. PLoS One 2010, 5:e9631.
25. Cho H.Y., Jedlicka A.E., Reddy S.P., Zhang L.Y., Kensler T.W., Kleeberger S.R. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am. J. Respir. Cell Mol. Biol. 2002, 26:42-51.
26. Itoh K., Mochizuki M., Ishii Y., Ishii T., Shibata T., Kawamoto Y., et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). Mol. Cell Biol. 2004, 24:36-45.
27. Cho H.Y., Reddy S.P., Yamamoto M., Kleeberger S.R. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J. 2004, 18:1258-1260.
28. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radical Biol. Med. 2004, 36:1199-1207.
29. Kaspar J.W., Niture S.K., Jaiswal A.K. Nrf2:INrf2 Keap1 signaling in oxidative stress. Free Radical Biol. Med. 2009, 47:1304-1309.
30. Lee I.T., Wang S.W., Lee C.W., Chang C.C., Lin C.C., Luo S.F., et al. Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells12. J. Immunol. 2008, 181:5098-5110.
31. Berg J.T., Lee S.T., Thepen T., Lee C.Y., Tsan M.F. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. J. Appl. Physiol. 1993, 74:2812-2819.
32. Broug-Holub E., Toews G.B., van Iwaarden J.F., Strieter R.M., Kunkel S.L., Paine R. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival1. Infect. Immun. 1997, 65:1139-1146.
33. Soehnlein O., Lindbom L. Phagocyte partnership during the onset and resolution of inflammation3. Nat. Rev. Immunol. 2010, 10:427-439.
34. Moi P., Chan K., Asunis I., Cao A., Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2) a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. USA 1994, 91:9926-9930.
35. Mochizuki M., Ishii Y., Itoh K., Iizuka T., Morishima Y., Kimura T., et al. Role of 15-deoxy delta (12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am. J. Respir. Crit. Care Med. 2005, 171:1260-1266.